Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HRT and cardiovascular disease.

Goran Samsioe1

  • 1Department of Obstetrics and Gynecology, Lund University Hospital, Lund, Sweden. goran.samsioe@gyn.lu.se

Annals of the New York Academy of Sciences
|December 3, 2003
PubMed
Summary

Hormone therapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary screening for increased fracture risk by the FRAX® questionnaire-uptake rates in relation to invitation method.

Archives of osteoporosis·2019
Same author

EMAS position statement: The ten point guide to the integral management of menopausal health.

Maturitas·2015
Same author

Associations between cadmium exposure and circulating levels of sex hormones in postmenopausal women.

Environmental research·2014
Same author

Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.

Maturitas·2014
Same author

Alcohol use and early mortality in Swedish middle-aged women: Nine-year follow-up of the Women's Health in Lund Area study.

Scandinavian journal of public health·2014
Same author

To pick, choose, or single out.

Menopause (New York, N.Y.)·2013

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Pharmacology

Background:

  • Randomized trials have not confirmed cardiovascular benefits of hormone therapy.
  • Observational and experimental data suggest potential cardiovascular benefits of female sex steroids, particularly estrogen.
  • Conflicting results highlight the complexity of hormone therapy's cardiovascular effects.

Purpose of the Study:

  • To reconcile conflicting findings on hormone therapy and cardiovascular disease.
  • To explore the role of estrogen in cardiovascular health.
  • To identify specific populations and administration methods for potential therapeutic benefits.

Main Methods:

  • Review of randomized controlled trials (e.g., WHI).
  • Analysis of observational and experimental data in humans and animals.
  • Consideration of different hormone therapy types, doses, and administration routes (oral vs. transdermal).

Main Results:

  • Transdermal estrogens may not increase venous thrombosis risk, unlike oral preparations.
  • Estrogen might prevent arteriosclerosis, but rapid cardiovascular effects could be negative.
  • Discordant results between cohort studies and randomized trials require further explanation.

Conclusions:

  • Estrogen's cardiovascular benefits are plausible but complex and context-dependent.
  • Future research should focus on defining target populations and optimal administration for hormone therapy.
  • The current understanding of hormone therapy's cardiovascular impact is incomplete, necessitating continued investigation.

Related Experiment Videos